BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4305626)

  • 1. Prevalence of antibodies to EB virus and other herpesviruses.
    Porter DD; Wimberly I; Benyesh-Melnick M
    JAMA; 1969 Jun; 208(9):1675-9. PubMed ID: 4305626
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serological study of the occurrence of Herpesviridae in French Guyana].
    Poveda JD; Babin M; Bonnici JF; du Pasquier P; Fleury HJ
    Bull Soc Pathol Exot Filiales; 1986; 79(2):207-12. PubMed ID: 3015441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of herpes- and adenovirus antibodies in patients with carcinoma of the cervix uteri. Measurement of antibodies to herpesvirus hominis (types 1 and 2), cytomegalovirus, EB-virus, and adenovirus.
    Vestergaard BF; Hornsleth A; Pedersen SN
    Cancer; 1972 Jul; 30(1):68-74. PubMed ID: 4339261
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.
    Schmidt NJ; Lennette EH; Magoffin RL
    J Gen Virol; 1969 Apr; 4(3):321-8. PubMed ID: 4306713
    [No Abstract]   [Full Text] [Related]  

  • 5. Infections with herpesviruses in a closed infants' community.
    Holý J; Vanĕcek K; Vonka V
    Arch Gesamte Virusforsch; 1973; 43(1):152-60. PubMed ID: 4367384
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased antibody to herpes simplex virus in patients with nasopharyngeal cancer.
    Palmer EL; Feorino PM; Martin ML
    J Infect Dis; 1972 Aug; 126(2):186-8. PubMed ID: 4340927
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to various herpesviruses in sera from patients with sarcoidosis.
    Wahren B; Carlens E; Espmark A; Lundbeck H; Löfgren S; Madar E; Henle G; Henle W
    J Natl Cancer Inst; 1971 Oct; 47(4):747-55. PubMed ID: 4328945
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the specificity of the complement fixation test in cytomegalovirus infections. With special reference to possible cross-reactions with other herpesvirus antigens.
    Andersen HK; Godtfredsen A; Spencer ES
    Scand J Infect Dis; 1971; 3(3):183-7. PubMed ID: 4331836
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery.
    Henle W; Henle G; Scriba M; Joyner CR; Harrison FS; Von Essen R; Paloheimo J; Klemola E
    N Engl J Med; 1970 May; 282(19):1068-74. PubMed ID: 4314606
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of an immunofluorescence technique for the determination of antibodies to cytomegalovirus strains in human sera.
    Chiang WT; Wentworth BB; Alexander ER
    J Immunol; 1970 Apr; 104(4):992-9. PubMed ID: 4315265
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening of antibodies to Herpes simplex virus in human sera by indirect immunofluorescence.
    Rajcáni J; Ravingerová E; Kocisková D; Szántó J
    Acta Virol; 1973 Jan; 17(1):61-8. PubMed ID: 4405398
    [No Abstract]   [Full Text] [Related]  

  • 12. [An epidemiological study of herpetic viral infections in the Republic of Byelarus].
    Kolomiets AG; Savitskaia TV; Matveev VA; Mel'nichenko EM; Zhukovskiĭ VG; Luk'ianenko IG; Sebut NS; Ospovat IaM; Kolomiets ND
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):24-9. PubMed ID: 9304321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of cytomegalovirus, herpes simplex, rubella, and toxoplasma antibodies in microcephalic, mentally retarded, and normocephalic children.
    Baron J; Youngblood L; Siewers MF; Medearis DN
    Pediatrics; 1969 Dec; 44(6):932-9. PubMed ID: 4312367
    [No Abstract]   [Full Text] [Related]  

  • 14. Human cytomegalovirus complement fixation studies.
    Dioşi P; Moldovan E; Baltiev A; Tîrnoveanu G
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):413-9. PubMed ID: 4328573
    [No Abstract]   [Full Text] [Related]  

  • 15. [Detection of antibodies against TORCH agents during pregnancy].
    Ustaçelebi S; Köksal I; Cantürk H; Saify SJ; Ersöz D; Sellioğlu B
    Mikrobiyol Bul; 1986 Jan; 20(1):1-8. PubMed ID: 3014280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A seroepidemiological study of herpes simplex virus.
    Hondo R
    Jpn J Med Sci Biol; 1974 Aug; 27(4):205-13. PubMed ID: 4369731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of complement-fixing antibodies against herpes simplex virus in a sample of population from Accra (Ghana)].
    Russo V; D'Arrigo C
    Ann Med Nav (Roma); 1968; 73(3):213-7. PubMed ID: 4310529
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the FIAX test for the detection of antibodies to herpes simplex virus and cytomegalovirus.
    Segar JE; Smith TF; Ilstrup DM
    Am J Clin Pathol; 1981 Mar; 75(3):387-90. PubMed ID: 6259930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple mathematical deductions in the seroepidemiology of viral infections. I. Herpesvirus group (herpesvirus hominis, varicella-zoster virus, cytomegalovris, Epstein-Barr-Virus).
    Doerr HW; Lehmair H; Schmitz H; Kampa D; Luthardt T
    Zentralbl Bakteriol Orig A; 1977 Jun; 238(2):149-64. PubMed ID: 196453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EB-virus antibodies in post-transfusion mononucleosis and cardiopulmonary bypass.
    Stevens DA; Pry TW
    J Med Microbiol; 1971 Feb; 4(1):13-8. PubMed ID: 4323398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.